Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Oragenics Inc (OGEN)

Oragenics Inc (OGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,328
  • Shares Outstanding, K 55,363
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,570 K
  • 60-Month Beta 0.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.09
  • Number of Estimates 1
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7400 +56.76%
on 07/06/20
2.0900 -44.50%
on 07/22/20
+0.4091 (+54.48%)
since 07/02/20
3-Month
0.4700 +146.81%
on 05/06/20
2.0900 -44.50%
on 07/22/20
+0.6117 (+111.56%)
since 05/04/20
52-Week
0.3500 +231.43%
on 08/15/19
2.0900 -44.50%
on 07/22/20
+0.7068 (+155.96%)
since 08/02/19

Most Recent Stories

More News
Data Shows Direct Link Between COVID-19 and Acute Respiratory Distress Syndrome (ARDS) In Infected Patients

, /PRNewswire/ -- There is a direct link between the COVID-19 virus and acute respiratory distress syndrome (ARDS) in COVID-19 patients. to the National Institutes of Health about 80% of COVID-19 infections...

OGEN : 1.1600 (-1.69%)
CTXR : 1.2900 (+2.38%)
DVAX : 9.01 (+0.56%)
PFE : 38.39 (+0.10%)
BNTX : 83.17 (-2.69%)
MRNA : 78.46 (+0.62%)
Thinking about buying stock in Oragenics Inc, Waitr Holdings, PDS Biotechnology, Novan Inc, or Ocugen Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OGEN, WTRH, PDSB, NOVN, and OCGN.

OGEN : 1.1600 (-1.69%)
Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies

Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or the "Company") announces that the National Institutes of Health (the "NIH") created stabilized pre-fusion spike protein (CoV-2 S-2P) licensed by the...

OGEN : 1.1600 (-1.69%)
Thinking about buying stock in WiMi Hologram Cloud, Oragenics Inc, Boeing, Matson Inc, or Cronos Group?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WIMI, OGEN, BA, MATX, and CRON.

BA : 165.07 (+1.73%)
MATX : 36.05 (-0.63%)
OGEN : 1.1600 (-1.69%)
Oragenics Provides Update on SARS-CoV-2 (COVID-19) Program

Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or "the Company") today provided an update on progress with its SARS-CoV-2 (COVID-19) vaccine candidate and announced the termination of its clinical...

OGEN : 1.1600 (-1.69%)
Oragenics, Inc. to Present at the June 2020 Virtual Summer Investor Summit

Oragenics, Inc. (NYSE American: OGEN), announced today that Alan Joslyn, Ph.D., President and CEO of Oragenics, Inc., will give a virtual corporate presentation at the June 2020 Virtual Summer Investor...

OGEN : 1.1600 (-1.69%)
47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th

The Virtual Summer Summit will take place on June 9-12, connecting 47 presenting small and microcap companies with distinguished investors from around the globe. A full list of issuers are listed below...

ACCO : 6.66 (-1.48%)
ALIM : 5.46 (-3.19%)
ANVS : 5.80 (+1.05%)
AQB : 3.47 (+6.12%)
ARTL : 1.1700 (unch)
AVLNF : 0.0570 (+0.53%)
BLCM : 7.17 (+0.56%)
NDRA : 0.9649 (+1.12%)
EFOI : 5.64 (+1.62%)
EQ : 10.37 (+2.67%)
EXROF : 0.6800 (+3.03%)
HL : 6.05 (+8.23%)
HSII : 19.85 (-2.46%)
HSDT : 0.5906 (+11.45%)
HGBL : 2.4000 (-8.05%)
IPWR : 7.92 (-4.00%)
LINC : 5.28 (+11.39%)
MBII : 1.1600 (unch)
MLSS : 1.8400 (-4.17%)
MYSZ : 1.3400 (+0.75%)
NBEV : 2.25 (+0.90%)
ONCS : 4.35 (-1.81%)
OGEN : 1.1600 (-1.69%)
SFE : 5.86 (+3.17%)
SLS : 3.57 (+2.29%)
PIXY : 4.83 (-2.23%)
SGLB : 2.80 (-3.78%)
SOTK : 3.0500 (unch)
TNXP : 1.2100 (-2.42%)
TGA : 0.6000 (+5.04%)
URG : 0.5899 (+5.58%)
Thinking about buying stock in Oragenics Inc, T2 Biosystems, Norwegian Cruise Lines, Sea Limited, or cbdMD Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OGEN, TTOO, NCLH, SE, and YCBD.

NCLH : 13.56 (+3.83%)
OGEN : 1.1600 (-1.69%)
SE : 137.51 (+3.59%)
TTOO : 1.5500 (-4.32%)
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate

Oragenics, Inc. (NYSE American: OGEN), (the "Company" or "Oragenics"), today announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an agreement with Aragen Bioscience,...

OGEN : 1.1600 (-1.69%)
Thinking about buying stock in Microvision, Oragenics, Roku, Mastech Digital, or Arch Coal?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MVIS, OGEN, ROKU, MHH, and ARCH.

ARCH : 31.42 (-0.22%)
MHH : 21.76 (+1.07%)
MVIS : 2.54 (+27.00%)
OGEN : 1.1600 (-1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade OGEN with:

Business Summary

Oragenics Inc is a biotechnology company focused on the development and licensure of innovative products and technologies for improving human health.

See More

Key Turning Points

2nd Resistance Point 1.2133
1st Resistance Point 1.1867
Last Price 1.1600
1st Support Level 1.1267
2nd Support Level 1.0933

See More

52-Week High 2.0900
Fibonacci 61.8% 1.4253
Fibonacci 50% 1.2200
Last Price 1.1600
Fibonacci 38.2% 1.0147
52-Week Low 0.3500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar